STOCK TITAN

IQVIA executive granted 2,722 shares, 806 withheld

IQVIA Holdings executive W. Richard Staub reported two equity-related transactions in common stock on February 8, 2026.

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

IQVIA Holdings executive W. Richard Staub reported two equity-related transactions in common stock on February 8, 2026. He received a grant of 2,722 shares at no cost, reflecting performance-based restricted stock units originally granted on February 13, 2023, after the Leadership Development and Compensation Committee determined the performance conditions were satisfied on February 8, 2026. On the same date, 806 shares were delivered to cover tax obligations at $187.49 per share. Following these transactions, Staub directly holds 18,812 shares of IQVIA common stock.

Positive

  • None.

Negative

  • None.
Insider STAUB W RICHARD
Role See Remarks
Type Security Shares Price Value
Grant/Award Common Stock 2,722 $0.00 $0.00
Exercise Price or Tax Liability Common Stock 806 $187.49 $151K
Holdings After Transaction: Common Stock — 18,812 shares (Direct)
Footnotes (1)
  1. F1. Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026.
Stock award shares 2,722 shares Common stock granted on 2026-02-08 from performance-based RSUs
Tax-withholding shares 806 shares Shares delivered to satisfy tax obligations on 2026-02-08
Tax-withholding price $187.49 per share Per-share value used for tax-liability share delivery
Post-transaction holdings 18,812 shares Direct IQVIA common stock held by W. Richard Staub after transactions
RSU grant date February 13, 2023 Date performance-based restricted stock units were originally granted
Performance satisfaction date February 8, 2026 Date committee determined RSU performance conditions were satisfied
performance-based restricted stock units financial
"Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023."
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
Leadership Development and Compensation Committee financial
"The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026."
tax liability financial
"Payment of exercise price or tax liability by delivering securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did IQV (IQVIA Holdings) executive W. Richard Staub report?

W. Richard Staub reported a grant of 2,722 IQVIA common shares and a tax-related disposition of 806 shares at $187.49 per share, both on February 8, 2026, linked to previously granted performance-based restricted stock units.

How many IQV (IQVIA Holdings) shares does W. Richard Staub hold after this Form 4?

After these transactions, W. Richard Staub directly holds 18,812 shares of IQVIA common stock. This post-transaction balance reflects the net result of his stock award vesting and the shares delivered to satisfy associated tax obligations.

What type of equity award did IQV (IQVIA Holdings) report for W. Richard Staub?

The reported award consists of performance-based restricted stock units that settled into 2,722 common shares. The performance criteria for this award, granted on February 13, 2023, were confirmed satisfied on February 8, 2026 by IQVIA’s Leadership Development and Compensation Committee.

What was the price used for the tax-withholding share disposition in IQV’s Form 4?

IQVIA’s Form 4 shows 806 shares delivered to cover tax obligations at a per-share value of $187.49. This transaction is coded as a tax-withholding disposition rather than an open-market sale and occurred on February 8, 2026.

Does the IQV (IQVIA Holdings) Form 4 mention a Rule 10b5-1 trading plan for these transactions?

The Form 4 data do not indicate that these transactions were executed under a Rule 10b5-1 trading plan. The activity relates to the vesting of performance-based restricted stock units and associated tax withholding, rather than discretionary market trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
STAUB W RICHARD

(Last) (First) (Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD

(Street)
DURHAM NC 27703

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/08/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/08/2026 A 2,722(1) A $0 19,618 D
Common Stock 02/08/2026 F 806 D $187.49 18,812 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026.
Remarks:
President, Research & Development Solutions
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub 02/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Keep reading